Molecular typing is based on molecular genetic screening and is not still routinely obtainable. Molecular subtypes and immunohistochemical surrogate markers of the tumors (HR, HER2, triple destructive) correlate in about 70%. The differentiation of luminal A and B subtypes by HR status and proliferation markers like Ki-67 may be https://charlesy119kwg1.blogsvirals.com/profile